These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31695435)

  • 1. Erratum: Synergistic Effect Of A Retinoid X Receptor-Selective Ligand Bexarotene And Docetaxel In Prostate Cancer [Corrigendum].
    Onco Targets Ther; 2019; 12():8807. PubMed ID: 31695435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of a retinoid X receptor-selective ligand bexarotene and docetaxel in prostate cancer.
    Shen D; Wang H; Zheng Q; Cheng S; Xu L; Wang M; Li GH; Xia LQ
    Onco Targets Ther; 2019; 12():7877-7886. PubMed ID: 31576145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of a retinoid X receptor-selective ligand bexarotene (LGD1069, Targretin) and paclitaxel (Taxol) in mammary carcinoma.
    Yen WC; Prudente RY; Lamph WW
    Breast Cancer Res Treat; 2004 Nov; 88(2):141-8. PubMed ID: 15564797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of bexarotene, a selective agonist of the retinoid receptor X (RXR), and tazarotene, a selective agonist of the retinoid acid receptor (RAR), on bone metabolism in rats.
    Nowak B; Matuszewska A; Filipiak J; Nikodem A; Merwid-Ląd A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A
    Adv Med Sci; 2016 Mar; 61(1):85-9. PubMed ID: 26569440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection [Corrigendum].
    Onco Targets Ther; 2021; 14():5167-5168. PubMed ID: 34729014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central hypothyroidism associated with retinoid X receptor-selective ligands.
    Sherman SI; Gopal J; Haugen BR; Chiu AC; Whaley K; Nowlakha P; Duvic M
    N Engl J Med; 1999 Apr; 340(14):1075-9. PubMed ID: 10194237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A selective retinoid X receptor agonist bexarotene (LGD1069, Targretin) prevents and overcomes multidrug resistance in advanced prostate cancer.
    Yen WC; Lamph WW
    Prostate; 2006 Feb; 66(3):305-16. PubMed ID: 16245282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nurr1 and Retinoid X Receptor Ligands Stimulate Ret Signaling in Dopamine Neurons and Can Alleviate α-Synuclein Disrupted Gene Expression.
    Volakakis N; Tiklova K; Decressac M; Papathanou M; Mattsson B; Gillberg L; Nobre A; Björklund A; Perlmann T
    J Neurosci; 2015 Oct; 35(42):14370-85. PubMed ID: 26490873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bexarotene-Activated Retinoid X Receptors Regulate Neuronal Differentiation and Dendritic Complexity.
    Mounier A; Georgiev D; Nam KN; Fitz NF; Castranio EL; Wolfe CM; Cronican AA; Schug J; Lefterov I; Koldamova R
    J Neurosci; 2015 Aug; 35(34):11862-76. PubMed ID: 26311769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum: Downregulation of miR-486-5p Enhances the Anti-Tumor Effect of 5-Fluorouracil on Pancreatic Cancer Cells [Corrigendum].
    Onco Targets Ther; 2020; 13():4507-4508. PubMed ID: 32547081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: Upregulated LINC00565 Accelerates Ovarian Cancer Progression by Targeting GAS6 [Corrigendum].
    Onco Targets Ther; 2020; 13():865-866. PubMed ID: 32099390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum: ACAT2 Promotes Cell Proliferation and Associates with Malignant Progression in Colorectal Cancer [Corrigendum].
    Onco Targets Ther; 2021; 14():4641-4643. PubMed ID: 34511933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum: Metformin Promotes Beclin1-Dependent Autophagy to Inhibit the Progression of Gastric Cancer [Corrigendum].
    Onco Targets Ther; 2020; 13():8181. PubMed ID: 32904014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum: Circulating Serum Exosomal aHIF Is A Novel Prognostic Predictor For Epithelial Ovarian Cancer [Corrigendum].
    Onco Targets Ther; 2019; 12():9115. PubMed ID: 31806996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum: Downregulation of miR-575 Inhibits the Tumorigenesis of Gallbladder Cancer via Targeting P27 Kip1 [Corrigendum].
    Onco Targets Ther; 2020; 13():12365-12366. PubMed ID: 33293829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratum: Down-Regulation of USP8 Suppresses HER-3 Positive Gastric Cancer Cells Proliferation [Corrigendum].
    Onco Targets Ther; 2021; 14():5295-5296. PubMed ID: 34848972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erratum: PWP1 Promotes the Malignant Phenotypes of Lung Cancer Cells by Interacting with DVL2 and Merlin [Corrigendum].
    Onco Targets Ther; 2020; 13():10763-10764. PubMed ID: 33122914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratum: Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer [Corrigendum].
    Onco Targets Ther; 2019; 12():9793. PubMed ID: 31814736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum: Effects of Adenosine on Apoptosis of Ovarian Cancer A2780 Cells via ROS and Caspase Pathways [Corrigendum].
    Onco Targets Ther; 2020; 13():1871-1872. PubMed ID: 32184621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum:
    Onco Targets Ther; 2020; 13():10761. PubMed ID: 33116649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.